Heike Daldrup-Link, MD, PhD
University of California, San Francisco
MR imaging of ovarian cancer with folate-receptor targeted contrast agents
Folate-receptors are relatively absent in normal tissues but overexpressed on cancer cells. Therefore, folate-receptor targeted contrast agents have the potential to provide cancer specific imaging. By targeting these receptors so they will appear vividly in magnetic resonance imaging (MRI), this study seeks to improve the ability to diagnose ovarian cancer with a new imaging technique.
